Petr Ďulíček

1.2k total citations
55 papers, 329 citations indexed

About

Petr Ďulíček is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Petr Ďulíček has authored 55 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 23 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in Petr Ďulíček's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Petr Ďulíček is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Petr Ďulíček collaborates with scholars based in Czechia, Austria and France. Petr Ďulíček's co-authors include Martin Beránek, Milan Košťál, Petr Sadílek, Jana Hirmerová, J Malý, Liana Gercheva, Hans Carl Hasselbalch, Thomas Wolf, Róbert Královics and Rafał Drwiła and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Circulation Journal.

In The Last Decade

Petr Ďulíček

46 papers receiving 319 citations

Peers

Petr Ďulíček
Ravi Ranjan India
Tamara Everington United Kingdom
Anthea Greenway Australia
Valentina Djordjević Serbia
J. J. Michiels Netherlands
Joanna Rupa‐Matysek Poland
Sabine Struve Germany
Allen Greenwald Canada
Eduard J. Libourel Netherlands
Ferdows Atiq Netherlands
Ravi Ranjan India
Petr Ďulíček
Citations per year, relative to Petr Ďulíček Petr Ďulíček (= 1×) peers Ravi Ranjan

Countries citing papers authored by Petr Ďulíček

Since Specialization
Citations

This map shows the geographic impact of Petr Ďulíček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Ďulíček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Ďulíček more than expected).

Fields of papers citing papers by Petr Ďulíček

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Ďulíček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Ďulíček. The network helps show where Petr Ďulíček may publish in the future.

Co-authorship network of co-authors of Petr Ďulíček

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Ďulíček. A scholar is included among the top collaborators of Petr Ďulíček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Ďulíček. Petr Ďulíček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sadílek, Petr, et al.. (2023). Antithrombin Deficiency: Frequency in Patients with Thrombosis and Thrombophilic Families. SHILAP Revista de lepidopterología. 66(1). 19–23. 1 indexed citations
3.
4.
Beránek, Martin, et al.. (2022). Whole Blood Samples for Faster Real-Time PCR Analysis of Thrombophilic Mutations in SARS-CoV-2 Virus Positive Patients. Physiological Research. 71(3). 439–445. 1 indexed citations
5.
Košťál, Milan, et al.. (2020). Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide. Journal of Thrombosis and Thrombolysis. 51(1). 112–119. 8 indexed citations
6.
Ďulíček, Petr, et al.. (2020). Heparin-induced thrombocytopenia treated with fondaparinux: single center experience. International Angiology. 39(1). 76–81. 10 indexed citations
7.
Ďulíček, Petr. (2018). Treatment of polycythemia vera. Vnitřní lékařství. 64(10). 955–960.
8.
Voško, Milan R., Rafał Drwiła, Petr Ďulíček, et al.. (2017). Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases. Journal of Thrombosis and Thrombolysis. 43(3). 306–317. 39 indexed citations
9.
Ďulíček, Petr. (2016). Antiphospholipid syndrome and thrombosis. 30(1). 42–43. 1 indexed citations
10.
Beránek, Martin, et al.. (2014). Preparing compound heterozygous reference material using gene synthesis technology: a model of thrombophilic mutations. Biomedical Papers. 158(4). 539–543. 2 indexed citations
11.
Penka, Miroslav, et al.. (2013). [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].. PubMed. 59(6). 516–31.
12.
Blatný, Jan, et al.. (2011). Significance and causes of abnormal preoperative coagulation test results in children. Haemophilia. 18(3). e297–301. 10 indexed citations
13.
Schwarz, Jiřı́, Miroslav Penka, Petra Ovesná, et al.. (2011). Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,. Blood. 118(21). 3857–3857. 1 indexed citations
14.
Reid, Robert L., Carolyn Westhoff, Diana Mansour, et al.. (2010). Oral Contraceptives and Venous Thromboembolism. Journal of Family Planning and Reproductive Health Care. 36(3). 117–122. 43 indexed citations
15.
Schwarz, Jiřı́, Robert Pytlík, Michael Doubek, et al.. (2006). Analysis of Risk Factors: The Rationale of the Guidelines of the Czech Hematological Society for Diagnosis and Treatment of Chronic Myeloproliferative Disorders with Thrombocythemia. Seminars in Thrombosis and Hemostasis. 32(3). 231–245. 6 indexed citations
16.
Ďulíček, Petr, et al.. (2003). [Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma].. PubMed. 82(11). 583–6. 5 indexed citations
17.
Ďulíček, Petr, J Malý, & Maya Safarova. (2000). Risk of Thrombosis in Patients Homozygous and Heterozygous for Factor V Leiden in the East Bohemian Region. Clinical and Applied Thrombosis/Hemostasis. 6(2). 87–89. 6 indexed citations
18.
Ďulíček, Petr, et al.. (1999). Is Factor V Leiden a Risk Factor for Fetal Loss?. Acta Medica (Hradec Kralove Czech Republic). 42(3). 93–96. 7 indexed citations
19.
Chrobák, L, et al.. (1997). Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine. Acta Medica (Hradec Kralove Czech Republic). 40(2). 41–45. 1 indexed citations
20.
Chrobák, L & Petr Ďulíček. (1996). Resistance to activated protein C as pathogenic factor of venous thromboembolism.. PubMed. 39(2). 55–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravi Ranjan Breakdown of academic impact, for papers by Tamara Everington Breakdown of academic impact, for papers by Anthea Greenway Breakdown of academic impact, for papers by Valentina Djordjević Breakdown of academic impact, for papers by J. J. Michiels Breakdown of academic impact, for papers by Joanna Rupa‐Matysek Breakdown of academic impact, for papers by Sabine Struve Breakdown of academic impact, for papers by Allen Greenwald Breakdown of academic impact, for papers by Eduard J. Libourel Breakdown of academic impact, for papers by Ferdows Atiq
Rankless by CCL
2026